BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9135075)

  • 1. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy.
    Pirollo KF; Hao Z; Rait A; Jang YJ; Fee WE; Ryan P; Chiang Y; Chang EH
    Oncogene; 1997 Apr; 14(14):1735-46. PubMed ID: 9135075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL; el-Naggar AK; Roth JA; Zhang WW; Goepfert H; Taylor DL; Liu TJ
    Cancer Res; 1995 Jan; 55(1):1-6. PubMed ID: 7805018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y
    Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma.
    Araki K; Ahmad SM; Li G; Bray DA; Saito K; Wang D; Wirtz U; Sreedharan S; O'Malley BW; Li D
    Clin Cancer Res; 2008 Jun; 14(11):3514-9. PubMed ID: 18519784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC; Wildner O
    Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
    Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Shigehara H; Konouchi H; Hisatomi M; Kawasaki S; Hiraki Y; Kishi K
    Oncol Rep; 2003; 10(3):671-7. PubMed ID: 12684642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts.
    Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M
    Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
    Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
    Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoradiotherapy combined with adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Konoucni H; Hisatomi M; Yanagi Y; Honda Y; Shigehara H; Kishi K
    Oncol Rep; 2003; 10(2):415-20. PubMed ID: 12579282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K; Cowan KH; Sinha BK
    Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T; Sun SY; Lotan R; Fujiwara T; Yasumatsu R; Komiyama S; Clayman GL
    Laryngoscope; 2001 Aug; 111(8):1459-64. PubMed ID: 11568584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
    Frank DK; Frederick MJ; Liu TJ; Clayman GL
    Clin Cancer Res; 1998 Oct; 4(10):2521-8. PubMed ID: 9796986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs1 protein.
    Rhee JG; Li D; Suntharalingam M; Guo C; O'Malley BW; Carney JP
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):273-8. PubMed ID: 17189075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM; Liu TJ; Taylor DL; Wang M; El-Naggar AK; Shillitoe E; Adler-Storthz K; John LS; Zhang WW; Roth JA; Clayman GL
    Clin Cancer Res; 1997 Feb; 3(2):185-91. PubMed ID: 9815671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA
    Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.